Preferential amplification of apoptotic DNA from plasma: potential for enhancing detection of minor DNA alterations in circulating DNA.
作者信息
Mamon Harvey, Hader Carlos, Li Jin, Wang Lilin, Kulke Matthew, Amicarelli Giulia, Shehi Erlet, Adlerstein Daniel, Roper Kristin, Killion Leah, Hooshmand Susanne, Makrigiorgos G Mike
出版信息
Clin Chem. 2008 Sep;54(9):1582-4. doi: 10.1373/clinchem.2008.104612.
Abstract
摘要
相似文献
1
Preferential amplification of apoptotic DNA from plasma: potential for enhancing detection of minor DNA alterations in circulating DNA.
Clin Chem. 2008 Sep;54(9):1582-4. doi: 10.1373/clinchem.2008.104612.
2
A colorimetric method for detection of K-ras codon 12 point mutations in DNA extracted from tissue and peripheral blood in pancreatic disorders.
Biochem Genet. 2010 Aug;48(7-8):577-89. doi: 10.1007/s10528-010-9340-5. Epub 2010 Apr 11.
3
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma.
Lung Cancer. 2011 Oct;74(1):118-23. doi: 10.1016/j.lungcan.2011.01.029. Epub 2011 Apr 8.
4
Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Nov;110(5):632-7. doi: 10.1016/j.tripleo.2010.05.002. Epub 2010 Sep 1.
5
Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer.
Clin Chim Acta. 2014 Jun 10;433:284-9. doi: 10.1016/j.cca.2014.03.024. Epub 2014 Mar 29.
6
Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.
J Thorac Oncol. 2009 Jan;4(1):5-11. doi: 10.1097/JTO.0b013e3181913e0e.
7
Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.
J Thorac Oncol. 2010 May;5(5):591-6. doi: 10.1097/JTO.0b013e3181d0a4db.
8
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.
Am J Clin Pathol. 2009 Oct;132(4):500-5. doi: 10.1309/AJCPF10ZUNSOLIFG.
9
Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies.
Clin Chem. 2015 Oct;61(10):1299-304. doi: 10.1373/clinchem.2015.242453. Epub 2015 Aug 13.
10
Large serrated polyp with KRAS mutation in inflammatory bowel disease: a "nondysplastic dysplasia-associated lesion or mass (DALM)"?
Endoscopy. 2013;45 Suppl 2 UCTN:E235-6. doi: 10.1055/s-0033-1344321. Epub 2013 Aug 14.
引用本文的文献
1
Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer.
Int J Mol Sci. 2023 Sep 21;24(18):14388. doi: 10.3390/ijms241814388.
2
Tumor Markers and Their Diagnostic Significance in Ovarian Cancer.
Life (Basel). 2023 Aug 5;13(8):1689. doi: 10.3390/life13081689.
3
Circulating DNA fragmentomics and cancer screening.
Cell Genom. 2023 Jan 11;3(1):100242. doi: 10.1016/j.xgen.2022.100242.
4
Early Detection of Ovarian Cancer.
Hematol Oncol Clin North Am. 2018 Dec;32(6):903-914. doi: 10.1016/j.hoc.2018.07.003. Epub 2018 Sep 28.
5
Single-tube, highly parallel mutation enrichment in cancer gene panels by use of temperature-tolerant COLD-PCR.
Clin Chem. 2015 Jan;61(1):267-77. doi: 10.1373/clinchem.2014.228361. Epub 2014 Oct 8.
6
Direct quantification of cell-free, circulating DNA from unpurified plasma.
PLoS One. 2014 Mar 3;9(3):e87838. doi: 10.1371/journal.pone.0087838. eCollection 2014.
7
Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment.
Clin Chem. 2012 Jul;58(7):1130-8. doi: 10.1373/clinchem.2012.183095. Epub 2012 May 15.
8
High fragmentation characterizes tumour-derived circulating DNA.
PLoS One. 2011;6(9):e23418. doi: 10.1371/journal.pone.0023418. Epub 2011 Sep 6.
9
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts.
Nucleic Acids Res. 2010 Oct;38(18):6159-75. doi: 10.1093/nar/gkq421. Epub 2010 May 21.
10
Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer.
Clin Cancer Res. 2009 Apr 15;15(8):2630-6. doi: 10.1158/1078-0432.CCR-08-2592. Epub 2009 Apr 7.
本文引用的文献
1
FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations.
Nucleic Acids Res. 2007;35(19):e131. doi: 10.1093/nar/gkm809. Epub 2007 Oct 11.
2
Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.
J Mol Diagn. 2006 Feb;8(1):22-30. doi: 10.2353/jmoldx.2006.050074.
3
Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms.
Clin Chem. 2004 Jun;50(6):1002-11. doi: 10.1373/clinchem.2003.029835. Epub 2004 Apr 8.
4
Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA.
Clin Chem. 2004 Jan;50(1):211-3. doi: 10.1373/clinchem.2003.026914.
5
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.
Cancer Res. 2001 Feb 15;61(4):1659-65.
Zotero 插件